Navigation Links
Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific

LONDON, July 11, 2014 /PRNewswire/ --

On Thursday, July 10, 2014, the NASDAQ Composite ended at 4,396.20, down 0.52%, the Dow Jones Industrial Average finished the day 0.42% lower at 16,915.07, and the S&P 500 closed at 1,964.68, down 0.41%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 711.88, down 0.02%, while the index has advanced 2.75% in the last one month. Investor-Edge has initiated coverage on the following equities: Covidien PLC (NYSE: COV), Baxter International Inc. (NYSE: BAX), DexCom Inc. (NASDAQ: DXCM) and Boston Scientific Corp. (NYSE: BSX). Free technical research on COV, BAX, DXCM and BSX can be downloaded upon signing up at:

On Thursday, Covidien PLC's stock recorded a trading volume of 3.65 million shares, lower than its three months average volume of 4.42 million shares. The stock finished the day at $91.00, up 0.10%, and registered an intraday range of $89.90 and $91.25. Covidien PLC's shares have rallied 24.69% in the last one month and 29.65% in the previous three months. Also, the stock has advanced 33.63% on YTD basis. Furthermore, the company's stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $78.29 is above its 200-day moving average of $70.23. Additionally, shares of the company traded at a PE ratio of 24.73 and have a Relative Strength Index (RSI) of 75.19. Sign up today to read free research on COV at:

Baxter International Inc.'s stock gained 1.23%, to close Thursday's session at $76.75, after hitting a new 52-week high of $76.78. The stock recorded a trading volume of 3.31 million shares, above its three months average volume of 2.60 million shares. Over the last one month and previous three months, Baxter International Inc.'s shares have surged 4.08% and 6.21%, respectively. Also, from the beginning of 2014, the company's stock has gained 10.35%. The stock is trading above its 50-day and 200-day moving averages. The company stock's 50-day moving average of $74.12 is above its 200-day moving average of $69.85. Further, the company's stock traded at a PE ratio of 15.82 and has an RSI of 66.00. Sign up today to read free research on BAX at:

On Thursday, DexCom Inc.'s stock finished the session 0.66% lower at $35.93. A total of 0.42 million shares were traded, which was below its three months average volume of 0.90 million shares. The stock moved between $34.67 and $36.39 during the session. Over the last one month and past three months, DexCom Inc.'s shares have lost 3.10% and 0.33%, respectively. However, the stock has gone up 1.47% since the start of this year. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $35.89 is greater than its 50-day moving average of $35.32. DexCom Inc.'s stock has an RSI of 41.43. Sign up today to read free research on DXCM at:

Shares in Boston Scientific Corp. fluctuated between $12.83 and $13.10 before ending Thursday's session up 0.61%, at an intra-day high of $13.10. The company's stock reported a trading volume of 10.08 million shares, below its three months average volume of 12.56 million shares. Further, shares of Boston Scientific Corp. have advanced 0.61% over the past three trading sessions and 2.02% over the last one month. Also, the stock has surged 8.99% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $12.84 is greater than its 200-day moving average of $12.62. Moreover, shares of the company traded at a PE ratio of 28.86 and have an RSI of 55.62. Sign up today to read free research on BSX at:


1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at]

5. For any urgent concerns or inquiries, please contact us at compliance [at]

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] for consideration.

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
3. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
5. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
9. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
10. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
11. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
Post Your Comments:
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/25/2015)... Nov. 25, 2015  Linden Care, LLC, a retail ... outcomes for patients suffering from chronic pain, said today ... Temporary Restraining Order (TRO) enjoining Express Scripts from unilaterally ... --> --> The ... its legal options. --> ...
(Date:11/25/2015)... 25, 2015  Henry Schein, Inc., the world,s largest ... dental, medical and animal health practitioners, will unveil at ... Henry Schein ConnectDental® Pavilion , which brings together for ... solutions designed to help any practice or laboratory enter ... for a schedule of experts appearing at the Pavilion. ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 27, 2015 , ... The men and women on this ... in the country. They have overseen financial turnarounds, shown commitment to their community ... industry as a whole through their advocacy and professional efforts. , Becker's Hospital ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer ... incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product ... Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not only ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical laboratories and ... offered by healthcare staffing agency Aureus Medical Group . These fields, ... 2015 among those searching for healthcare jobs through the company’s website, ...
(Date:11/26/2015)... CA (PRWEB) , ... November 26, 2015 , ... ... a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly ... options. These classically-influenced trailer titles work with any font, giving users limitless opportunities ...
Breaking Medicine News(10 mins):